ABCG34 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to ABCG34 Antibody

The ABCG34 antibody targets the ATP-binding cassette (ABC) transporter protein ABCG34, a membrane-localized protein involved in the secretion of camalexin, a phytoalexin critical for defense against necrotrophic pathogens . This antibody enables researchers to detect ABCG34 expression, localization, and functional roles in plant-pathogen interactions.

Functional Role of ABCG34 in Plant Defense

ABCG34 mediates the secretion of camalexin, a sulfur-containing antimicrobial compound, to the leaf surface. Key findings include:

  • Camalexin Transport:

    • atabcg34 mutants secreted ~30–50% less camalexin than wild-type plants, while overexpressors showed enhanced secretion .

    • Camalexin accumulation on leaf surfaces directly correlates with resistance to Alternaria brassicicola and Botrytis cinerea .

  • Pathogen Sensitivity:

    • atabcg34 mutants exhibited hypersensitivity to sclareol (an antifungal diterpene) and necrotrophic fungi .

    • Overexpression of ABCG34 increased resistance by >2-fold in pathogen challenge assays .

Table 1: Functional Outcomes of ABCG34 Modulation in Arabidopsis

Plant LineCamalexin SecretionPathogen Resistance (vs. Wild Type)Sensitivity to Sclareol
Wild TypeBaselineBaselineBaseline
atabcg34 mutant↓ 30–50%↓ 50–70%↑ Hypersensitive
ABCG34 Overexpr.↑ 60–80%↑ 100–120%↓ Tolerant

Table 2: ABCG34 Localization and Induction

ParameterObservationMethod Used
Tissue LocalizationPlasma membrane of epidermal cellsGFP tagging
Inducing FactorsMethyl-jasmonate, A. brassicicola infectionGUS reporter assays

Applications in Scientific Studies

  • Localization Studies:
    ABCG34 antibodies confirm polar localization at the plasma membrane using confocal microscopy (e.g., GFP-tagged constructs) .

  • Functional Assays:

    • Western Blotting: Quantifies ABCG34 expression in mutant vs. overexpressor lines .

    • Pathogen Resistance Assays: Evaluates camalexin secretion and fungal growth inhibition .

  • Genetic Variant Analysis:
    Natural Arabidopsis accessions with higher ABCG34 expression show ~15–20% greater disease resistance .

Technical Considerations

  • Antibody Validation: Specificity is confirmed via knockout controls (e.g., atabcg34 mutants showing no signal) .

  • Experimental Limitations:

    • Camalexin toxicity requires careful handling in transport assays .

    • Pathogen assays depend on controlled environmental conditions to minimize variability .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ABCG34 antibody; PDR6 antibody; At2g36380 antibody; F1O11.1 antibody; ABC transporter G family member 34 antibody; ABC transporter ABCG.34 antibody; AtABCG34 antibody; Pleiotropic drug resistance protein 6 antibody
Target Names
ABCG34
Uniprot No.

Target Background

Function
ABCG34 may function as a general defense protein.
Gene References Into Functions
  1. AtABCG34 mediates camalexin secretion to the leaf surface, thereby preventing Abrassicicola infection. PMID: 28652324
Database Links

KEGG: ath:AT2G36380

STRING: 3702.AT2G36380.1

UniGene: At.43047

Protein Families
ABC transporter superfamily, ABCG family, PDR (TC 3.A.1.205) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed in roots at low levels.

Q&A

FAQ: ABCG34 Antibody Research in Academic Context
Curated for experimental biologists and plant pathology researchers

Advanced Research Questions

How to resolve contradictions in ABCG34’s contribution to disease resistance across natural Arabidopsis accessions?

  • Hypothesis: Genetic background influences compensatory mechanisms (e.g., redundant transporters like ABCG36).

  • Method: GWAS on 100+ accessions using:

    • Phenotyping: Lesion size post-A. brassicicola inoculation.

    • Genotyping: SNPs in ABCG34 promoter/coding regions.

    • Multi-omics correlation: Transcript levels vs. camalexin secretion rates .

What controls are critical when analyzing ABCG34’s polar localization in epidermal cells?

  • Technical controls:

    • Co-stain with plasma membrane marker (e.g., PIP2A-mCherry).

    • Use abcg34 mutants to confirm signal specificity.

  • Biological controls:

    • Induce expression with methyl-jasmonate (100 µM, 24h) to validate stress-responsive trafficking .

    • Compare root vs. leaf epidermal cells for tissue-specific polarity.

How to design a study evaluating ABCG34’s interaction with other defense pathways?

  • Step 1: Transcriptomic profiling of abcg34 mutants under jasmonate/ethylene treatment.

  • Step 2: Co-immunoprecipitation (Co-IP) with:

    • Camalexin biosynthetic enzymes (e.g., CYP71A13).

    • Signaling kinases (e.g., MPK3/6).

  • Step 3: Metabolite flux analysis using ¹⁴C-labeled camalexin in mutant/transgenic lines .

Data Conflict Analysis Framework

Scenario: Discrepancy in ABCG34’s role across pathogen species (e.g., strong effect on A. brassicicola vs. weak on B. cinerea).

  • Root-cause analysis:

    • Compare camalexin sensitivity of pathogens (e.g., B. cinerea may degrade camalexin via detox enzymes).

    • Assess ABCG34 induction kinetics—time-course qRT-PCR post-inoculation (Fig. 3C in ).

    • Test combinatorial mutants (e.g., abcg34/pad3) to uncouple camalexin-dependent/independent effects .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.